Active Surveillance Offers Functional Advantages Without Impacting Survival for Low-risk Prostate Cancer.
Eur Urol. 2018 Jun;73(6):868-869. doi: 10.1016/j.eururo.2017.10.037. Epub 2017 Nov 21.
Eur Urol. 2018.
PMID: 29169932
No abstract available.